摘要
目的探讨大黄蟅虫丸抗肝纤维化的作用机理。方法建立四氯化碳(CCl4)复合因素肝纤维化大鼠模型,观察大黄蟅虫丸对模型动物转化生长因子β1(TGFβ1)、基质金属蛋白酶组织抑制因子1(TIMP-1)的影响。结果大黄蟅虫丸能显著抑制大鼠血清中的TGFβ1、TIMP-1、透明质酸酶(HA)、层粘连蛋白(LN)、Ⅲ型前胶原(PCⅢ)、IV型胶原(CIV)、谷丙转氨酶(ALT)、谷草转氨酶(AST)的表达。结论大黄蟅虫丸对肝纤维化形成中两个重要因子TGFβ1和TIMP-1表达的抑制作用,可能是其抗肝纤维化的作用机理之一。
ObjectiveTo explore the protective mechanism of Dahuangzhechongwan on hepatic fibrosis. MethodsRat fibrosis model was established by CCl4 compound factors.Transforming growth factor β1(TGFβ1),tissue inhibitor of metalloproteinase-1(TIMP-1) were detected in the serum among different groups. ResultsDahuangzhechongwan could reduce the serum levels of TGFβ1,TIMP-1,Hyaluronic Acid(HA),Laminin(LN),Procolagen Type Ⅲ(PCⅢ),Collagen TypeⅣ(CⅣ),glutamic-pyruvic transaminase(ALT) and glutamic-oxalacetic transaminase(AST),respectively. ConclusionDahuangzhechongwan can inhibit the expression of TGFβ1 and TIMP-1,the two main factors were related to the occurrence of hepatic fibrosis.This may be one of the mechanisms which Dahuangzhechongwan restrains the progression of liver fibrosis.
出处
《时珍国医国药》
CAS
CSCD
北大核心
2012年第4期801-802,共2页
Lishizhen Medicine and Materia Medica Research
基金
国家自然科学基金(No.30271627)
广东省自然科学基金(No.020337)